Most read article(s)

Clinical/Scientific Note
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
Virginia Palomares Cabeza, Laura Y.L. Kummer, Luuk Wieske, et al.

May 06, 2022
Diagnostic and Treatment Challenges
A young man with numbness in arms and legsFrom the National Multiple Sclerosis Society Case Conference Proceedings
Andrew R. Romeo, Robert P. Lisak, Ethan Meltzer, et al.

October 23, 2018
Clinical/Scientific Note
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies
Chiara Briani, Andrea Visentin, Francesca Castellani, et al.

May 16, 2022
Research Article
MRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA ReceptorA Case Series
Bo Deng, Mengfei Cai, Yue Qiu, et al.

March 25, 2022
Article
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum DisorderA Retrospective, Cross-sectional Analysis
Jannis Müller, Tim Sinnecker, Maria Janina Wendebourg, et al.

February 25, 2022
Article
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune EncephalitisReal-world Evidence From the GENERATE Registry
Franziska S. Thaler, Luise Zimmermann, Stefan Kammermeier, et al.

October 01, 2021
Article
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis
Margherita Nosadini, Terrence Thomas, Michael Eyre, et al.

July 22, 2021
Research Article
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
Marta Pengo, Silvia Miante, Silvia Franciotta, et al.

May 23, 2022
Research Article
Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple SclerosisClinical, Radiographic, and Laboratory Data
William M. Rowles, Wan-Yu Hsu, Kira McPolin, et al.

May 17, 2022
Article
Vitamin D enhances responses to interferon-β in MS
Xuan Feng, Zhe Wang, Quentin Howlett-Prieto, et al.

October 03, 2019

Pages